Xiaoxiao Liu

机构：Kunming Medical University, Second Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0001-5430-8834

发表论文 5 篇 · 总被引 30 次 · h-index 4

代表论文

• CD39 inhibitor (POM-1) enhances radiosensitivity of esophageal squamous cell carcinoma (ESCC) cells by promoting apoptosis through the Bax/Bcl-2/Caspase 9/Caspase 3 pathway (2024 · International Immunopharmacology · 被引 9)
• METTL3 regulatory TROAP can regulate the progression of non-small cell lung cancer through PI3K/AKT and EMT signaling pathway (2023 · Medical Oncology · 被引 8)
• ELMO1 regulates macrophage directed migration and attenuates inflammation via NF-κB signaling pathway in primary biliary cholangitis (2024 · Digestive and Liver Disease · 被引 6)
• PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer (2023 · Medical Oncology · 被引 5)
• Association of eczema with risk of pan-cancers: a two-sample Mendelian randomization study (2024 · Oncology and Translational Medicine · 被引 2)